Skip to Content

Cancer Treatment Startup Based on U Research Wins Tekne Award

picture of award

A startup company that develops next-generation cancer treatments based on University of Minnesota research has been awarded for its innovative therapies.

GeneSegues Therapeutics received the Minnesota High Tech Association’s Tekne Award Wednesday night in the category of Health Care — Small and Growing. Tekne Awards recognize innovation across Minnesota in industries ranging from advanced manufacturing, health care and agricultural technology.

GeneSegues develops microscopic capsules that serve as a vessel to transport gene therapies through the body that help stop the spread of cancer. The capsules are smaller than conventional nanoparticles, allowing them to slip past the human body’s biological barriers and attack cancerous cells more precisely, while leaving healthy cells unharmed.

The company grew out of research done by U of M post-doc Gretchen Unger, Ph.D., in the early 2000s. Unger is currently chief scientific officer with the company. The company’s CEO is Laura Brod, who is also an at-large member of the University’s Board of Regents.

Kevin Coss

Kevin Coss

Kevin is a communications specialist with the Office of the Vice President for Research.

coss@umn.edu

Latest Blog Posts

Illustration of a nova explosion in space.

'White dwarf' stars going supernova likely spewed seeds of our solar system.

Read More
Strangely shaped carrots and potatoes

Researchers are exploring the aesthetic factors that make produce acceptable in consumers' eyes—and how to market imperfect-looking, but nutritious, food.

Read More
Microscope lit by sunlight

Some researchers can now return to on-site work as part of a plan meant to allow for more research activity while still limiting the coronavirus's spread.

Read More
Prototype of the COVID-19 testing device

The MagiCoil detects the virus in blood and respiratory material and delivers results in as little as 10 minutes via smartphone.

Read More